NT-proBNP rapid test RAMP®

for cardiovascular diseasespneumoniaBNP

Response Biomedical offers a FDA cleared whole blood immunoassay NT-proBNP test, with our proprietary RAMP technology which detects the levels of N-terminal prohormone of brain natriuretic peptide in patients with congestive heart failure around the world. Read more about how this product will help your physicians and patients where a traditional BNP test cannot. MANAGING PATIENTS WITH HEART FAILURE 1 out of 4 patients will be readmitted within 30 days of discharge, the highest rate of readmission of any discharge diagnosis 1 in 5 patients diagnosed with heart failure die within the first year and about half of people who develop heart failure die within 5 years of diagnosis Heart failure often presents with non-specific symptoms and is frequently confused with pneumonia or COPD Heart attacks and Coronary Heart Disease are two of the most expensive conditions to treat. RAMP NT-PROBNP TEST Provides rapid, accurate diagnoses and assessment of congestive heart failure. NT-proBNP is roughly 5 times more stable of a biomarker then BNP Better accuracy in mild heart failure patients because the levels of NT-proBNP are 2-10x higher Standardized to Roche Elecsys Lab Analyzer TEST PRINCIPLES Quantitative fluorescent immunoassay Single use test cartridge with barcode defines lot specific calibration Proprietary RAMP® buffer enhances performance A calibrated transfer device is provided with every kit RAMP ratio corrects for sources of analytical variability A calibrated transfer device is provided with every kit